Neurovascular Devices Market

7500+ companies worldwide approach us every year for their revenue growth initiatives
Global top 2000 strategist rely on us for their growth strategies.
80% of fortune 2000 companies rely on our research to identify new revenue sources.
30000 High Growth Opportunities
95% renewal rate
KNOW MORE
  1. HOME
  2. Top Market Reports
  3. Neurovascular Devices Market

Neurovascular Devices Market by Disease Pathology (Cerebral Ameurysm (Embolic coils), Ischemic Stroke (Clot retrievers, Aspiration, Microcatheters), AVM (Liquid Embolic Agents), End User (Hospitals), & Region - Global Forecast to 2028

FREE BROCHURE FREE SAMPLE REPORT
Report Code: MD 1310 May, 2023, by marketsandmarkets.com

The global neurovascular devices market in terms of revenue was estimated to be worth $3.6 billion in 2023 and is poised to reach $5.5 billion by 2028, growing at a CAGR of 8.7% from 2023 to 2028. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. The growth in this market is attributed to the increase in the prevalence of various neurovascular diseases, rising adoption of minimally invasive surgical procedures,  expansion of healthcare infrastructure in emerging countries, and strategic collaborations & partnerships among manufacturers and research institutes to boost the new developments in interventional neurology. However, high cost of neurovascular interventional procedures & related devices  to pose a barrier towards the adoption of neurovascular treatment, especially in developing countries with poor reimbursement policies.

Attractive Opportunities in the Neurovascular Devices Market

Neurovascular Devices Market

To know about the assumptions considered for the study, Request for Free Sample Report

Neurovascular Devices Market

Neurovascular Devices Market Dynamics

DRIVER: Growing prevalence of neurovascular diseases

With proven clinical efficacy, interventional therapeutic procedures are being adopted for better diagnosis, monitoring, and therapy for neurological conditions. The significant adoption of neurovascular devices can be mainly attributed to the large and rapidly growing patient population base for target diseases across the key markets. According to the World Stroke Organization (WSO) in 2022, around 7.6 million new ischemic stroke cases were registered worldwide. Globally, a larger proportion of the population is at risk of developing neurovascular diseases as a result of the growing prevalence of obesity, high blood pressure, smoking, and surge in geriatric patient population. According to CDC, the risk of developing stroke is doubling every 10 years after the age 55. All these factors are anticipated to boost the demand for neurovascular interventional devices in the coming years.

RESTRAINT: High procedural cost of neurovascular surgeries and associated products

The high cost of neurovascular surgical procedures and devices is a major factor restraining the global market, especially in developing countries with poor reimbursement policies. Additionally, maintenance costs and other associated indirect expenses increase the total cost of ownership of these devices, thereby limiting their adoption. Owing to high costs and a poor reimbursement scenario, a very limited pool of patients in developing countries can afford neurological treatment. As a result, healthcare facilities are reluctant to invest in new or technologically advanced systems, thus limiting the market.

OPPORTUNITY: Rising number of research activities for neurovascular therapies

Neurovascular devices are witnessing a growing demand among the major stakeholders globally, due to increasing clinical research activities in the field of neurovascular therapies, which offer credible clinical data related to their safety & efficacy profiles. Moreover, the growing emphasis by patients on effective, accurate and early diagnoses of target diseases is driving the number of industry-academia collaborations, investments in clinical studies aimed at the development and commercialization of innovative and therapeutically diverse neurovascular products. In 2021, EIT Health-supported start-up, Oxford Endovascular (UK), raised USD 10 million to boost the research & development of novel neurovascular devices for the treatment of ischemic stroke.

Neurovascular Devices Market Ecosystem

Prominent companies in this neurovascular devices industry include well-established, financially stable manufacturers of neurovascular devices systems, reagent, gel documentation systems and software. These companies have been operating in the market for several years and possess a diversified product portfolio, state-of-the-art technologies, and strong global sales and marketing networks. Prominent companies in this market include Stryker (US), Johnson & Johnson (US), Medtronic plc (US), Terumo Corporation (Japan), and Penumbra, Inc. (US).

Neurovascular Devices Market Ecosystem

In 2022, Ischemic stroke segment of neurovascular devices industry, to observe highest growth rate during the forecast period, by disease pathology

Based on disease pathology, the neurovascular devices market is segmented into cerebral aneurysm, ischemic strokes, carotid artery stenosis, arteriovenous malformations & fistulas, and other disease pathologies. The ischemic stroke segment is anticipated to grow at the highest CAGR during the forecast period. This can be attributed to the growing  prevalence of ischemic stroke globally, increasing number of ischemic stroke patients undergoing mechanical thrombectomy procedures; and the rising focus of manufacturers on boosting R&D to launch technologically advanced neurovascular interventional devices such as clot retrieval devices and aspiration catheters for the treatment of Ischemic stroke 

In 2022, hospitals & surgical centers segment to dominate the neurovascular devices industry, by end user

Based on end user, the neurovascular devices market is segmented into hospitals & surgical centers, ambulatory care centers, and research laboratories and academic institutes. The hospital & surgical centers captured the largest share of market during the forecast period. This can be attributed to the rising hospitalized patient volume with neurovascular disease in hospitals, expansion of hospital infrastructure in developing countries, and growing availability of cutting-edge technologies in hospitals to boost neurovascular treatment.

In 2022, North America to dominate in neurovascular devices industry

The global neurovascular devices market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. North America is expected to dominate during the forecast period, due to the significant rise in the burden of neurovascular diseases, continued expansion of ambulatory care facilities, increasing volume of minimally invasive procedures and growing reimbursement for various neurovascular conditions.

Neurovascular Devices Market by Region

To know about the assumptions considered for the study, download the pdf brochure

The neurovascular devices market is dominated by players such Stryker (US), Johnson & Johnson (US), Medtronic plc (US), Terumo Corporation (Japan), and Penumbra, Inc. (US).

Scope of the Neurovascular Devices Industry

Report Metric 

Details 

Market Revenue in 2023

$3.6 billion

Projected Revenue by 2028

$5.5 billion

Revenue Rate

Poised to grow at a CAGR of 8.7%

Market Driver

Growing prevalence of neurovascular diseases

Market Opportunity

Rising number of research activities for neurovascular therapies

This research report categorizes the neurovascular devices market to forecast revenue and analyze trends in each of the following submarkets:

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

By Disease Pathology

  • Cerebral Aneurysm
    • Embolic coils
    • Flow Diversion Devices
    • Microcatheters
    • Intracranial Stent
    • Guidewires
  • Ischemic Stroke
    • Clot Retrievers Devices 
    • Suction and Aspiration Devices
    • Vascular Snares
    • Microcatheter
    • Microguidewires
    • Balloon  Guide Catheters
  • Carotid Artery Stenosis
    • Carotid Artery Stents
    • Embolic Protection Devices
    • Balloon Catheters
  • Arteriovenous Malformation & Fistulas
    • Liquid Embolic Agents
    • Microcatheters
    • Occlusion Balloon Catheters
  • Other Disease Pathologies

By End User

  • Hospitals & Surgical Centers
  • Ambulatory Care Centers
  • Research Laboratories And  Academic Institutes

Recent Developments of Neurovascular Devices Industry

  • In December 2022, Stryker (US) established a new research & development facility at International Park, Gurgaon, India, intending to accelerate innovations in neurovascular devices for stroke treatment
  • In February 2022,  Johnson & Johnson (US) launched the EMBOGUARD, a balloon guide catheter for treating acute ischemic stroke.
  • In January 2021, Penumbra, Inc.(US) and Genesis Medtech (Australia) collaborated to expand Penumbra’s market capabilities in China by commercializing and producing novel neurovascular products in China. 

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS
 
1 INTRODUCTION (Page No. - 34)
    1.1 STUDY OBJECTIVES 
    1.2 NEUROVASCULAR DEVICES INDUSTRY DEFINITION 
           1.2.1 INCLUSIONS AND EXCLUSIONS
    1.3 STUDY SCOPE 
           1.3.1 MARKETS COVERED
           1.3.2 GEOGRAPHIC SCOPE
           1.3.3 YEARS CONSIDERED
    1.4 CURRENCY CONSIDERED 
    1.5 MARKET STAKEHOLDERS 
    1.6 RECESSION IMPACT 
 
2 RESEARCH METHODOLOGY (Page No. - 39)
    2.1 RESEARCH DATA 
          FIGURE 1 RESEARCH DESIGN
           2.1.1 SECONDARY DATA
           2.1.2 PRIMARY RESEARCH
                    2.1.2.1 Key data from primary sources
                                FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
                                FIGURE 3 NEUROVASCULAR DEVICES MARKET: BREAKDOWN OF PRIMARIES
    2.2 MARKET SIZE ESTIMATION 
          FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
           2.2.1 PRODUCT-BASED MARKET ESTIMATION
           2.2.2 VOLUME-BASED MARKET ESTIMATION
                    FIGURE 5 MARKET SIZE ESTIMATION: MARKET
           2.2.3 PRIMARY RESEARCH VALIDATION
    2.3 DATA TRIANGULATION 
          FIGURE 6 DATA TRIANGULATION METHODOLOGY
    2.4 RESEARCH ASSUMPTIONS AND LIMITATIONS 
           2.4.1 RESEARCH ASSUMPTIONS
           2.4.2 RESEARCH LIMITATIONS
    2.5 RECESSION IMPACT 
          TABLE 1 GLOBAL INFLATION RATE PROJECTION, 2021–2027 (% GROWTH)
 
3 EXECUTIVE SUMMARY (Page No. - 49)
    FIGURE 7 NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2023 VS. 2028 (USD MILLION)
    FIGURE 8 HOSPITALS AND SURGICAL CENTERS SEGMENT TO CONTINUE TO DOMINATE MARKET DURING FORECAST PERIOD
    FIGURE 9 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN MARKET DURING FORECAST PERIOD
 
4 PREMIUM INSIGHTS (Page No. - 52)
    4.1 NEUROVASCULAR DEVICES MARKET OVERVIEW 
    4.2 MARKET, BY DISEASE PATHOLOGY, 2023 VS. 2028 (USD MILLION) 
          FIGURE 10 CEREBRAL ANEURYSMS TO DOMINATE MARKET DURING FORECAST PERIOD
    4.3 NEUROVASCULAR DEVICES INDUSTRY, BY REGION AND DISEASE PATHOLOGY (2022) 
          FIGURE 11 CEREBRAL ANEURYSMS SEGMENT ACCOUNTED FOR HIGHEST MARKET SHARE IN US
    4.4 GLOBAL MARKET, BY COUNTRY 
          FIGURE 12 CHINA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
 
5 MARKET OVERVIEW (Page No. - 56)
    5.1 INTRODUCTION 
    5.2 MARKET DYNAMICS 
          FIGURE 13 NEUROVASCULAR DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
           5.2.1 DRIVERS
                    5.2.1.1 Rising incidence of neurovascular diseases
                                FIGURE 14 PROPORTION OF GERIATRIC TO TOTAL WORLD POPULATION, BY COUNTRY, 2020 VS. 2030 (MILLION PEOPLE)
                    5.2.1.2 Availability of medical reimbursements for neurovascular procedures
                                TABLE 2 US: REIMBURSEMENT FOR INTERVENTIONAL NEUROLOGY PROCEDURES
                    5.2.1.3 Expansion of healthcare infrastructure across emerging economies
                    5.2.1.4 Rising demand for effective neurovascular therapies
           5.2.2 RESTRAINTS
                    5.2.2.1 Shortage of skilled neurosurgeons
                    5.2.2.2 High procedural cost of neurovascular surgeries and associated products
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Rising R&D activities for neurovascular therapies
                    5.2.3.2 Growing preference for minimally invasive neurosurgical procedures
           5.2.4 CHALLENGES
                    5.2.4.1 Stringent regulatory approval process for medical devices
    5.3 SUPPLY CHAIN ANALYSIS 
          FIGURE 15 MARKET: SUPPLY CHAIN ANALYSIS
    5.4 VALUE CHAIN ANALYSIS 
          FIGURE 16 VALUE CHAIN ANALYSIS: MAXIMUM VALUE ADDED THROUGH REGULATION & DISTRIBUTION STAGES
    5.5 PORTER’S FIVE FORCES ANALYSIS 
           5.5.1 OVERVIEW
                    TABLE 3 MARKET: PORTER’S FIVE FORCES ANALYSIS
           5.5.2 THREAT OF NEW ENTRANTS
           5.5.3 THREAT OF SUBSTITUTES
           5.5.4 BARGAINING POWER OF SUPPLIERS
           5.5.5 BARGAINING POWER OF BUYERS
           5.5.6 INTENSITY OF COMPETITIVE RIVALRY
    5.6 REGULATORY LANDSCAPE 
           5.6.1 NORTH AMERICA
                    5.6.1.1 US
                                TABLE 4 US FDA: MEDICAL DEVICE CLASSIFICATION
                                TABLE 5 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
                    5.6.1.2 Canada
           5.6.2 EUROPE
           5.6.3 ASIA PACIFIC
                    5.6.3.1 China
                    5.6.3.2 Japan
                    5.6.3.3 India
                    5.6.3.4 South Korea
    5.7 REIMBURSEMENT SCENARIO 
          TABLE 6 REIMBURSEMENT CODES FOR VARIOUS PROCEDURES (2021)
    5.8 PRICING TREND ANALYSIS 
           5.8.1 AVERAGE SELLING PRICE OF NEUROVASCULAR DEVICES, BY KEY PLAYER, 2021 (USD)
           5.8.2 AVERAGE SELLING PRICE OF NEUROVASCULAR DEVICES, BY REGION/COUNTRY, 2021 (USD)
    5.9 PATENT ANALYSIS 
          FIGURE 17 TOP PATENT APPLICANTS FOR ORTHOPEDIC DEVICES, JANUARY 2012–MARCH 2023
    5.10 TRADE ANALYSIS 
           TABLE 7 IMPORT DATA FOR HS CODE 901890, BY COUNTRY, 2017–2021 (USD MILLION)
           TABLE 8 EXPORT DATA FOR HS CODE 901890, BY COUNTRY, 2016–2020 (USD MILLION)
    5.11 ECOSYSTEM MAP 
    5.12 CASE STUDY ANALYSIS 
           5.12.1 STENT-ASSISTED COILING (SAC) THERAPY FOR INTRACRANIAL ANEURYSMS
                     TABLE 9 USAGE OF INTRACRANIAL STENTS FOR TREATMENT OF BROAD-NECKED INTRACRANIAL ANEURYSMS
    5.13 KEY CONFERENCES AND EVENTS IN 2022–2023 
           TABLE 10 MARKET: DETAILED LIST OF CONFERENCES AND EVENTS
           FIGURE 18 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
    5.14 STAKEHOLDERS AND BUYING CRITERIA 
           5.14.1 KEY STAKEHOLDERS
                     FIGURE 19 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR KEY APPLICATIONS
                     TABLE 11 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR KEY APPLICATION SEGMENTS (%)
    5.15 KEY BUYING CRITERIA 
           FIGURE 20 KEY BUYING CRITERIA FOR NEUROVASCULAR DEVICES
           TABLE 12 KEY BUYING CRITERIA FOR NEUROVASCULAR DEVICES
 
6 NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY (Page No. - 83)
    6.1 INTRODUCTION 
          TABLE 13 NEUROVASCULAR DEVICES INDUSTRY, BY DISEASE PATHOLOGY, 2021–2028 (USD MILLION)
          TABLE 14 MARKET, BY REGION, 2021–2028 (USD MILLION)
          TABLE 15 MARKET, BY END USER, 2021–2028 (USD MILLION)
    6.2 CEREBRAL ANEURYSMS 
          TABLE 16 MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 17 MARKET FOR CEREBRAL ANEURYSMS, BY REGION, 2021–2028 (USD MILLION)
          TABLE 18 GLOBAL MARKET FOR CEREBRAL ANEURYSMS, BY END USER, 2021–2028 (USD MILLION)
           6.2.1 EMBOLIC COILS
                    TABLE 19 CEREBRAL ANEURYSMS MARKET FOR EMBOLIC COILS, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 20 CEREBRAL ANEURYSMS MARKET FOR EMBOLIC COILS, BY TYPE, 2021–2028 (USD MILLION)
                    6.2.1.1 Bare detachable coils
                               6.2.1.1.1 Significant adoption of bare detachable coils by neurosurgeons for brain aneurysm treatment to promote growth
                                              TABLE 21 CEREBRAL ANEURYSMS MARKET FOR BARE DETACHABLE COILS, BY REGION, 2021–2028 (USD MILLION)
                    6.2.1.2 Coated detachable coils
                               6.2.1.2.1 High cost of coated detachable coils to limit adoption
                                              TABLE 22 CEREBRAL ANEURYSMS MARKET FOR COATED DETACHABLE COILS, BY REGION, 2021–2028 (USD MILLION)
           6.2.2 FLOW DIVERSION DEVICES
                    6.2.2.1 Rising R&D activities to develop novel flow diversion devices to promote growth
                                TABLE 23 CEREBRAL ANEURYSMS MARKET FOR FLOW DIVERSION DEVICES, BY REGION, 2021–2028 (USD MILLION)
           6.2.3 INTRACRANIAL STENTS
                    6.2.3.1 Increased efficacy of stent-assisted coiling for treatment of wide-necked intracranial aneurysms to boost adoption
                                TABLE 24 CEREBRAL ANEURYSMS MARKET FOR INTRACRANIAL STENTS, BY REGION, 2021–2028 (USD MILLION)
           6.2.4 MICROCATHETERS
                    6.2.4.1 Growing number of neurovascular procedures and favorable reimbursement scenarios to boost demand
                                TABLE 25 CEREBRAL ANEURYSMS MARKET FOR MICROCATHETERS, BY REGION, 2021–2028 (USD MILLION)
           6.2.5 GUIDEWIRES
                    6.2.5.1 Growing utilization of nitinol guidewires for cerebral aneurysm procedures to boost growth
                                TABLE 26 CEREBRAL ANEURYSMS MARKET FOR GUIDEWIRES, BY REGION, 2021–2028 (USD MILLION)
    6.3 ISCHEMIC STROKES 
          TABLE 27 MARKET FOR ISCHEMIC STROKE, BY REGION, 2021–2028 (USD MILLION)
          TABLE 28 MARKET FOR ISCHEMIC STROKE, BY TYPE 2021–2028 (USD MILLION)
          TABLE 29 MARKET FOR ISCHEMIC STROKE, BY END USER, 2021–2028 (USD MILLION
           6.3.1 CLOT RETRIEVER DEVICES
                    6.3.1.1 Growing number of clinical trials for development of novel clot retriever stents to drive market
                                TABLE 30 ISCHEMIC STROKES MARKET FOR CLOT RETRIEVER DEVICES, BY REGION, 2021–2028 (USD MILLION)
           6.3.2 SUCTION & ASPIRATION DEVICES
                    6.3.2.1 Rapid commercialization of technologically advanced aspiration devices for ischemic stroke treatment to support market
                                TABLE 31 ISCHEMIC STROKES MARKET FOR SUCTION & ASPIRATION DEVICES, BY REGION, 2021–2028 (USD MILLION)
           6.3.3 VASCULAR SNARES
                    6.3.3.1 Limited procedural benefits in stroke treatment to limit adoption of vascular snares
                                TABLE 32 ISCHEMIC STROKES MARKET FOR VASCULAR SNARES, BY REGION, 2021–2028 (USD MILLION)
           6.3.4 MICROCATHETERS
                    6.3.4.1 High demand for minimally invasive treatment in ischemic strokes to boost adoption of microcatheters
                                TABLE 33 ISCHEMIC STROKES MARKET FOR MICROCATHETERS, BY REGION, 2021–2028 (USD MILLION)
           6.3.5 MICROGUIDEWIRES
                    6.3.5.1 Increasing innovations in guidewires to promote growth
                                TABLE 34 ISCHEMIC STROKES MARKET FOR MICROGUIDEWIRES, BY REGION, 2021–2028 (USD MILLION)
           6.3.6 BALLOON CATHETERS
                    6.3.6.1 Growing recognition of benefits associated with balloon catheters to bolster demand
                                TABLE 35 ISCHEMIC STROKES MARKET FOR BALLOON CATHETERS, BY REGION, 2021–2028 (USD MILLION)
    6.4 CAROTID ARTERY STENOSIS 
          TABLE 36 NEUROVASCULAR DEVICES INDUSTRY FOR ARTERIOVENOUS CAROTID ARTERY STENOSIS, BY REGION, 2021–2028 (USD MILLION)
          TABLE 37 MARKET FOR CAROTID ARTERY STENOSIS, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 38 MARKET FOR CAROTID ARTERY STENOSIS, BY END USER, 2021–2028 (USD MILLION)
           6.4.1 CAROTID ARTERY STENTS
                    6.4.1.1 Growing adoption of carotid artery stents for carotid intervention procedures to support growth
                                TABLE 39 CAROTID ARTERY STENOSIS MARKET FOR CAROTID ARTERY STENTS, BY REGION, 2021–2028 (USD MILLION)
           6.4.2 EMBOLIC PROTECTION DEVICES
                    6.4.2.1 Growing utilization of distal filters during carotid intervention procedures to promote growth
                                TABLE 40 CAROTID ARTERY STENOSIS MARKET FOR EMBOLIC PROTECTION DEVICES, BY REGION, 2021–2028 (USD MILLION)
           6.4.3 BALLOON CATHETERS
                    6.4.3.1 Growing preference for balloon catheters to improve efficacy of carotid intervention procedures to augment growth
                                TABLE 41 CAROTID ARTERY STENOSIS MARKET FOR BALLOON CATHETERS, BY REGION, 2021–2028 (USD MILLION)
    6.5 ARTERIOVENOUS MALFORMATION & FISTULAS 
          TABLE 42 MARKET FOR ARTERIOVENOUS MALFORMATION & FISTULAS, BY REGION, 2021–2028 (USD MILLION)
          TABLE 43 MARKET FOR ARTERIOVENOUS MALFORMATION & FISTULAS, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 44 GLOBAL MARKET FOR ARTERIOVENOUS MALFORMATION & FISTULAS, BY END USER, 2021–2028 (USD MILLION)
           6.5.1 LIQUID EMBOLIC AGENTS
                    6.5.1.1 Development of novel liquid embolic agents offering high embolization of arteriovenous fistulas to support growth
                                TABLE 45 ARTERIOVENOUS MALFORMATION & FISTULAS MARKET FOR LIQUID EMBOLIC AGENTS, BY REGION, 2021–2028 (USD MILLION)
           6.5.2 OCCLUSION BALLOON CATHETERS
                    6.5.2.1 Growing utilization of balloon catheters for AVM treatment to support growth
                                TABLE 46 ARTERIOVENOUS MALFORMATION & FISTULAS MARKET FOR OCCLUSION BALLOON CATHETERS, BY REGION, 2021–2028 (USD MILLION)
           6.5.3 MICROCATHETERS
                    6.5.3.1 Improved compatibility of microcatheters with embolic agents to boost demand
                                TABLE 47 ARTERIOVENOUS MALFORMATION & FISTULAS MARKET FOR MICROCATHETERS, BY REGION, 2021–2028 (USD MILLION)
    6.6 OTHER DISEASE PATHOLOGIES 
          TABLE 48 MARKET FOR OTHER DISEASE PATHOLOGIES, BY REGION, 2021–2028 (USD MILLION)
          TABLE 49 MARKET FOR OTHER DISEASE PATHOLOGIES, BY END USER, 2021–2028 (USD MILLION)
 
7 NEUROVASCULAR DEVICES MARKET, BY END USER (Page No. - 109)
    7.1 INTRODUCTION 
          TABLE 50 MARKET, BY END USER, 2021–2028 (USD MILLION)
    7.2 HOSPITALS AND SURGICAL CENTERS 
           7.2.1 INCREASING VOLUME OF NEUROVASCULAR PROCEDURES DUE TO AVAILABILITY OF ADVANCED EQUIPMENT TO DRIVE MARKET
                    TABLE 51 MARKET FOR HOSPITALS AND SURGICAL CENTERS, BY REGION, 2021–2028 (USD MILLION)
    7.3 AMBULATORY CARE CENTERS 
           7.3.1 OPERATIONAL AND ECONOMIC BENEFITS OFFERED BY ACCS TO DRIVE MARKET
                    TABLE 52 NEUROVASCULAR DEVICES INDUSTRY FOR AMBULATORY CARE CENTERS, BY REGION, 2021–2028 (USD MILLION)
    7.4 RESEARCH LABORATORIES AND ACADEMIC INSTITUTES 
           7.4.1 INCREASING COLLABORATIONS FOR DEVELOPMENT OF TECHNOLOGICALLY ADVANCED NEUROVASCULAR DEVICES TO SUPPORT MARKET GROWTH
                    TABLE 53 MARKET FOR RESEARCH LABORATORIES AND ACADEMIC INSTITUTES, BY REGION, 2021–2028 (USD MILLION)
 
8 NEUROVASCULAR DEVICES MARKET, BY REGION (Page No. - 114)
    8.1 INTRODUCTION 
          TABLE 54 MARKET, BY REGION, 2021–2028 (USD MILLION)
    8.2 NORTH AMERICA 
           8.2.1 NORTH AMERICA: RECESSION IMPACT
                    FIGURE 21 MARKET: NORTH AMERICA SNAPSHOT
                    TABLE 55 NORTH AMERICA: NEUROVASCULAR DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 56 NORTH AMERICA: MARKET, BY DISEASE PATHOLOGY, 2021–2028 (USD MILLION)
                    TABLE 57 NORTH AMERICA: MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 58 NORTH AMERICA: CEREBRAL ANEURYSMS MARKET FOR EMBOLIC COILS, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 59 NORTH AMERICA: MARKET FOR ISCHEMIC STROKES, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 60 NORTH AMERICA: MARKET FOR CAROTID ARTERY STENOSIS, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 61 NORTH AMERICA: MARKET FOR ARTERIOVENOUS MALFORMATIONS AND FISTULAS, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 62 NORTH AMERICA: NEUROVASCULAR DEVICES INDUSTRY, BY END USER, 2021–2028 (USD MILLION)
           8.2.2 US
                    8.2.2.1 Presence of established neurovascular device manufacturers to drive market
                                TABLE 63 US: NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2021–2028 (USD MILLION)
                                TABLE 64 US: MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 65 US: EMBOLIC COILS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 66 US: MARKET FOR ISCHEMIC STROKES, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 67 US: MARKET FOR CAROTID ARTERY STENOSIS, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 68 US: MARKET FOR ARTERIOVENOUS MALFORMATIONS AND FISTULAS, BY TYPE, 2021–2028 (USD MILLION)
           8.2.3 CANADA
                    8.2.3.1 Large target pool for ischemic stroke patients to drive market
                                TABLE 69 CANADA: NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2021–2028 (USD MILLION)
                                TABLE 70 CANADA: MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 71 CANADA: EMBOLIC COILS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 72 CANADA: MARKET FOR ISCHEMIC STROKES, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 73 CANADA: MARKET FOR CAROTID ARTERY STENOSIS, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 74 CANADA: NEUROVASCULAR DEVICES INDUSTRY FOR ARTERIOVENOUS MALFORMATIONS AND FISTULAS, BY TYPE, 2021–2028 (USD MILLION)
    8.3 EUROPE 
           8.3.1 EUROPE: RECESSION IMPACT
                    TABLE 75 EUROPE: NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2021–2028 (USD MILLION)
                    TABLE 76 EUROPE: MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 77 EUROPE: CEREBRAL ANEURYSMS MARKET FOR EMBOLIC COILS, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 78 EUROPE: MARKET FOR ISCHEMIC STROKES, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 79 EUROPE: MARKET FOR CAROTID ARTERY STENOSIS, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 80 EUROPE: MARKET FOR ARTERIOVENOUS MALFORMATIONS AND FISTULAS, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 81 EUROPE: MARKET, BY END USER, 2021–2028 (USD MILLION)
           8.3.2 GERMANY
                    8.3.2.1 Increasing adoption of endovascular coils and stents to drive market
                                TABLE 82 GERMANY: NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2021–2028 (USD MILLION)
                                TABLE 83 GERMANY: MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 84 GERMANY: CEREBRAL ANEURYSMS MARKET FOR EMBOLIC COILS, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 85 GERMANY: MARKET FOR ISCHEMIC STROKES, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 86 GERMANY: MARKET FOR CAROTID ARTERY STENOSIS, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 87 GERMANY: MARKET FOR ARTERIOVENOUS MALFORMATIONS AND FISTULAS, BY TYPE, 2021–2028 (USD MILLION)
           8.3.3 FRANCE
                    8.3.3.1 Growing preference for minimally invasive neurovascular procedures to drive market
                                TABLE 88 FRANCE: NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2021–2028 (USD MILLION)
                                TABLE 89 FRANCE: MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 90 FRANCE: CEREBRAL ANEURYSMS MARKET FOR EMBOLIC COILS, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 91 FRANCE: MARKET FOR ISCHEMIC STROKE, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 92 FRANCE: MARKET FOR CAROTID ARTERY STENOSIS, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 93 FRANCE: NEUROVASCULAR DEVICES INDUSTRY FOR ARTERIOVENOUS MALFORMATIONS AND FISTULAS, BY TYPE, 2021–2028 (USD MILLION)
           8.3.4 UK
                    8.3.4.1 Rising government initiatives to increase accessibility of neurovascular procedures to drive market
                                TABLE 94 UK: NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2021–2028 (USD MILLION)
                                TABLE 95 UK: MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 96 UK: CEREBRAL ANEURYSMS MARKET FOR EMBOLIC COILS, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 97 UK: MARKET FOR ISCHEMIC STROKES, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 98 UK: MARKET FOR CAROTID ARTERY STENOSIS, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 99 UK: MARKET FOR ARTERIOVENOUS MALFORMATIONS AND FISTULAS, BY TYPE, 2021–2028 (USD MILLION)
           8.3.5 ITALY
                    8.3.5.1 Increasing thrombectomy treatment rates to drive demand for neurovascular devices
                                TABLE 100 ITALY: NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2021–2028 (USD MILLION)
                                TABLE 101 ITALY: MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 102 ITALY: CEREBRAL ANEURYSMS MARKET FOR EMBOLIC COILS, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 103 ITALY: MARKET FOR ISCHEMIC STROKES, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 104 ITALY: MARKET FOR CAROTID ARTERY STENOSIS, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 105 ITALY: MARKET FOR ARTERIOVENOUS MALFORMATIONS AND FISTULAS, BY TYPE, 2021–2028 (USD MILLION)
           8.3.6 SPAIN
                    8.3.6.1 Rising number of clinical trials for interventional neurovascular procedures to support market growth
                                TABLE 106 SPAIN: NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2021–2028 (USD MILLION)
                                TABLE 107 SPAIN: MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 108 SPAIN: CEREBRAL ANEURYSMS MARKET FOR EMBOLIC COILS, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 109 SPAIN: MARKET FOR ISCHEMIC STROKES, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 110 SPAIN: MARKET FOR CAROTID ARTERY STENOSIS, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 111 SPAIN: NEUROVASCULAR DEVICES INDUSTRY FOR ARTERIOVENOUS MALFORMATIONS AND FISTULAS, BY TYPE, 2021–2028 (USD MILLION)
           8.3.7 REST OF EUROPE
                    TABLE 112 REST OF EUROPE: NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2021–2028 (USD MILLION)
                    TABLE 113 REST OF EUROPE: MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 114 REST OF EUROPE: CEREBRAL ANEURYSMS MARKET FOR EMBOLIC COILS, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 115 REST OF EUROPE: MARKET FOR ISCHEMIC STROKES, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 116 REST OF EUROPE: MARKET FOR CAROTID ARTERY STENOSIS, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 117 REST OF EUROPE: MARKET FOR ARTERIOVENOUS MALFORMATIONS AND FISTULAS, BY TYPE, 2021–2028 (USD MILLION)
    8.4 ASIA PACIFIC 
           8.4.1 ASIA PACIFIC: RECESSION IMPACT
                    TABLE 118 ASIA PACIFIC: NEUROVASCULAR DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 119 ASIA PACIFIC: MARKET, BY DISEASE PATHOLOGY, 2021–2028 (USD MILLION)
                    TABLE 120 ASIA PACIFIC: MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 121 ASIA PACIFIC: CEREBRAL ANEURYSMS MARKET FOR EMBOLIC COILS, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 122 ASIA PACIFIC: MARKET FOR ISCHEMIC STROKES, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 123 ASIA PACIFIC: MARKET FOR CAROTID ARTERY STENOSIS, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 124 ASIA PACIFIC: MARKET FOR ARTERIOVENOUS MALFORMATIONS AND FISTULAS, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 125 ASIA PACIFIC: NEUROVASCULAR DEVICES INDUSTRY, BY END USER, 2021–2028 (USD MILLION)
                    FIGURE 22 MARKET: ASIA PACIFIC SNAPSHOT
           8.4.2 JAPAN
                    8.4.2.1 Favorable reimbursement policy for adoption of neurovascular procedures to drive market
                                TABLE 126 JAPAN: NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2021–2028 (USD MILLION)
                                TABLE 127 JAPAN: MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 128 JAPAN: CEREBRAL ANEURYSMS MARKET FOR EMBOLIC COILS, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 129 JAPAN: MARKET FOR ISCHEMIC STROKES, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 130 JAPAN: MARKET FOR CAROTID ARTERY STENOSIS, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 131 JAPAN: MARKET FOR ARTERIOVENOUS MALFORMATIONS AND FISTULAS, BY TYPE, 2021–2028 (USD MILLION)
           8.4.3 CHINA
                    8.4.3.1 Robust presence of neurovascular device manufacturers to drive market
                                TABLE 132 CHINA: NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2021–2028 (USD MILLION)
                                TABLE 133 CHINA: MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 134 CHINA: CEREBRAL ANEURYSMS MARKET FOR EMBOLIC COILS, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 135 CHINA: MARKET FOR ISCHEMIC STROKES, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 136 CHINA: MARKET FOR CAROTID ARTERY STENOSIS, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 137 CHINA: NEUROVASCULAR DEVICES INDUSTRY FOR ARTERIOVENOUS MALFORMATIONS AND FISTULAS, BY TYPE, 2021–2028 (USD MILLION)
           8.4.4 INDIA
                    8.4.4.1 Supportive government initiatives to drive uptake for neurovascular devices
                                TABLE 138 INDIA: NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2021–2028 (USD MILLION)
                                TABLE 139 INDIA: MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 140 INDIA: CEREBRAL ANEURYSMS MARKET FOR EMBOLIC COILS, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 141 INDIA: MARKET FOR ISCHEMIC STROKES, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 142 INDIA: MARKET FOR CAROTID ARTERY STENOSIS, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 143 INDIA: MARKET FOR ARTERIOVENOUS MALFORMATIONS AND FISTULAS, BY TYPE, 2021–2028 (USD MILLION)
           8.4.5 AUSTRALIA
                    8.4.5.1 Rising incidence of cerebrovascular disease to drive market
                                TABLE 144 AUSTRALIA: NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2021–2028 (USD MILLION)
                                TABLE 145 AUSTRALIA: MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 146 AUSTRALIA: CEREBRAL ANEURYSMS MARKET FOR EMBOLIC COILS, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 147 AUSTRALIA: MARKET FOR ISCHEMIC STROKES, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 148 AUSTRALIA: MARKET FOR CAROTID ARTERY STENOSIS, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 149 AUSTRALIA: NEUROVASCULAR DEVICES INDUSTRY FOR ARTERIOVENOUS MALFORMATIONS AND FISTULAS, BY TYPE, 2021–2028 (USD MILLION)
           8.4.6 SOUTH KOREA
                    8.4.6.1 Health insurance coverage for neurovascular procedures to support market growth
                                TABLE 150 SOUTH KOREA: NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2021–2028 (USD MILLION)
                                TABLE 151 SOUTH KOREA: MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 152 SOUTH KOREA: CEREBRAL ANEURYSMS MARKET FOR EMBOLIC COILS, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 153 SOUTH KOREA: MARKET FOR ISCHEMIC STROKES, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 154 SOUTH KOREA: MARKET FOR CAROTID ARTERY STENOSIS, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 155 SOUTH KOREA: MARKET FOR ARTERIOVENOUS MALFORMATIONS AND FISTULAS, BY TYPE, 2021–2028 (USD MILLION)
           8.4.7 REST OF ASIA PACIFIC
                    TABLE 156 REST OF ASIA PACIFIC: NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2021–2028 (USD MILLION)
                    TABLE 157 REST OF ASIA PACIFIC: MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 158 REST OF ASIA PACIFIC: CEREBRAL ANEURYSMS MARKET FOR EMBOLIC COILS, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 159 REST OF ASIA PACIFIC: MARKET FOR ISCHEMIC STROKES, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 160 REST OF ASIA PACIFIC: MARKET FOR CAROTID ARTERY STENOSIS, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 161 REST OF ASIA PACIFIC: MARKET FOR ARTERIOVENOUS MALFORMATIONS AND FISTULAS, BY TYPE, 2021–2028 (USD MILLION)
    8.5 LATIN AMERICA 
           8.5.1 LATIN AMERICA: RECESSION IMPACT
                    TABLE 162 LATIN AMERICA: NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2021–2028 (USD MILLION)
                    TABLE 163 LATIN AMERICA: MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 164 LATIN AMERICA: CEREBRAL ANEURYSMS MARKET FOR EMBOLIC COILS, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 165 LATIN AMERICA: MARKET FOR ISCHEMIC STROKES, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 166 LATIN AMERICA: MARKET FOR CAROTID ARTERY STENOSIS, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 167 LATIN AMERICA: MARKET FOR ARTERIOVENOUS MALFORMATIONS AND FISTULAS, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 168 LATIN AMERICA: NEUROVASCULAR DEVICES INDUSTRY, BY END USER, 2021–2028 (USD MILLION)
           8.5.2 BRAZIL
                    8.5.2.1 Increasing awareness initiatives on stroke symptoms to drive market
                                TABLE 169 BRAZIL: NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2021–2028 (USD MILLION)
                                TABLE 170 BRAZIL: MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 171 BRAZIL: CEREBRAL ANEURYSMS MARKET FOR EMBOLIC COILS, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 172 BRAZIL: MARKET FOR ISCHEMIC STROKES, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 173 BRAZIL: MARKET FOR CAROTID ARTERY STENOSIS, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 174 BRAZIL: NEUROVASCULAR DEVICES INDUSTRY FOR ARTERIOVENOUS MALFORMATIONS AND FISTULAS, BY TYPE, 2021–2028 (USD MILLION)
           8.5.3 MEXICO
                    8.5.3.1 Increasing incidence of neurovascular diseases to support market growth
                                TABLE 175 MEXICO: NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2021–2028 (USD MILLION)
                                TABLE 176 MEXICO: MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 177 MEXICO: CEREBRAL ANEURYSMS MARKET FOR EMBOLIC COILS, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 178 MEXICO: MARKET FOR ISCHEMIC STROKES, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 179 MEXICO: MARKET FOR CAROTID ARTERY STENOSIS, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 180 MEXICO: MARKET FOR ARTERIOVENOUS MALFORMATIONS AND FISTULAS, BY TYPE, 2021–2028 (USD MILLION)
           8.5.4 REST OF LATIN AMERICA
                    TABLE 181 REST OF LATIN AMERICA: NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2021–2028 (USD MILLION)
                    TABLE 182 REST OF LATIN AMERICA: MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 183 REST OF LATIN AMERICA: CEREBRAL ANEURYSMS MARKET FOR EMBOLIC COILS, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 184 REST OF LATIN AMERICA: MARKET FOR ISCHEMIC STROKES, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 185 REST OF LATIN AMERICA: MARKET FOR CAROTID ARTERY STENOSIS, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 186 REST OF LATIN AMERICA: NEUROVASCULAR DEVICES INDUSTRY FOR ARTERIOVENOUS MALFORMATIONS AND FISTULAS, BY TYPE, 2021–2028 (USD MILLION)
    8.6 MIDDLE EAST & AFRICA 
           8.6.1 SHORTAGE OF NEUROSURGEONS AND POOR HEALTHCARE COVERAGE TO RESTRAIN MARKET GROWTH
           8.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT
                    TABLE 187 MIDDLE EAST & AFRICA: NEUROVASCULAR DEVICES MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 188 MIDDLE EAST & AFRICA: MARKET, BY DISEASE PATHOLOGY, 2021–2028 (USD MILLION)
                    TABLE 189 MIDDLE EAST & AFRICA: CEREBRAL ANEURYSMS MARKET FOR EMBOLIC COILS, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 190 MIDDLE EAST & AFRICA: MARKET FOR ISCHEMIC STROKES, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 191 MIDDLE EAST & AFRICA: MARKET FOR CAROTID ARTERY STENOSIS, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 192 MIDDLE EAST & AFRICA: MARKET FOR ARTERIOVENOUS MALFORMATIONS & FISTULAS, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 193 MIDDLE EAST & AFRICA: NEUROVASCULAR DEVICES INDUSTRY, BY END USER, 2021–2028 (USD MILLION)
 
9 COMPETITIVE LANDSCAPE (Page No. - 185)
    9.1 INTRODUCTION 
           9.1.1 STRATEGIES ADOPTED BY KEY PLAYERS
                    FIGURE 23 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS (2019−2023)
    9.2 REVENUE SHARE ANALYSIS 
          FIGURE 24 REVENUE SHARE ANALYSIS OF TOP PLAYERS IN NEUROVASCULAR DEVICES MARKET
    9.3 MARKET SHARE ANALYSIS 
          FIGURE 25 MARKET SHARE, BY KEY PLAYER (2022)
    9.4 COMPETITIVE LEADERSHIP MAPPING: COMPANY EVALUATION QUADRANT (2022) 
           9.4.1 STARS
           9.4.2 EMERGING LEADERS
           9.4.3 PERVASIVE PLAYERS
           9.4.4 PARTICIPANTS
                    FIGURE 26 MARKET: COMPETITIVE LEADERSHIP MAPPING FOR KEY PLAYERS (2021)
    9.5 COMPETITIVE LEADERSHIP MAPPING: STARTUPS/SME EVALUATION QUADRANT (2022) 
           9.5.1 PROGRESSIVE COMPANIES
           9.5.2 RESPONSIVE COMPANIES
           9.5.3 DYNAMIC COMPANIES
           9.5.4 STARTING BLOCKS
                    FIGURE 27 MARKET: COMPETITIVE LEADERSHIP MAPPING FOR SMES/STARTUPS (2022)
    9.6 MARKET: FOOTPRINT ANALYSIS OF LEADING PLAYERS 
          TABLE 194 COMPANY FOOTPRINT ANALYSIS
          TABLE 195 PRODUCT FOOTPRINT
          TABLE 196 REGIONAL FOOTPRINT
           9.6.1 PRODUCT LAUNCHES & APPROVALS
                    TABLE 197 MARKET: KEY PRODUCT LAUNCHES & APPROVALS (JANUARY 2019–MARCH 2023)
           9.6.2 DEALS
                    TABLE 198 MARKET: KEY DEALS (JANUARY 2019–MARCH 2023)
           9.6.3 OTHER DEVELOPMENTS
                    TABLE 199 MARKET: OTHER DEVELOPMENTS (JANUARY 2019–MARCH 2023)
 
10 COMPANY PROFILES (Page No. - 198)
(Business Overview, Products Offered, Recent Developments, MnM View Right to win, Strategic choices made, Weaknesses and competitive threats) *
     10.1 KEY PLAYERS 
             10.1.1 STRYKER
                        TABLE 200 STRYKER: BUSINESS OVERVIEW
                        FIGURE 28 STRYKER: COMPANY SNAPSHOT (2022)
             10.1.2 MEDTRONIC
                        TABLE 201 MEDTRONIC: BUSINESS OVERVIEW
                        FIGURE 29 MEDTRONIC: COMPANY SNAPSHOT (2022)
             10.1.3 JOHNSON & JOHNSON
                        TABLE 202 JOHNSON & JOHNSON: BUSINESS OVERVIEW
                        FIGURE 30 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2022)
             10.1.4 TERUMO CORPORATION
                        TABLE 203 TERUMO CORPORATION: BUSINESS OVERVIEW
                        FIGURE 31 TERUMO CORPORATION: COMPANY SNAPSHOT (2021)
             10.1.5 PENUMBRA, INC.
                        TABLE 204 PENUMBRA, INC.: BUSINESS OVERVIEW
                        FIGURE 32 PENUMBRA, INC.: COMPANY SNAPSHOT (2022)
             10.1.6 MICROPORT SCIENTIFIC CORPORATION
                        TABLE 205 MICROPORT SCIENTIFIC CORPORATION: BUSINESS OVERVIEW
                        FIGURE 33 MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2022)
             10.1.7 BALT
                        TABLE 206 BALT: BUSINESS OVERVIEW
             10.1.8 KANEKA CORPORATION
                        TABLE 207 KANEKA CORPORATION: BUSINESS OVERVIEW
                        FIGURE 34 KANEKA CORPORATION: COMPANY SNAPSHOT (2022)
                        TABLE 208 PRODUCT LAUNCHES
             10.1.9 PHENOX GMBH
                        TABLE 209 PHENOX GMBH: BUSINESS OVERVIEW
             10.1.10 ASAHI INTECC CO., LTD
                        TABLE 210 ASAHI INTECC CO., LTD.: BUSINESS OVERVIEW
                        FIGURE 35 ASAHI INTECC: COMPANY SNAPSHOT (2022)
             10.1.11 PERFLOW MEDICAL LTD.
                        TABLE 211 PERFLOW MEDICAL LTD.: BUSINESS OVERVIEW
             10.1.12 RAPID MEDICAL
                        TABLE 212 RAPID MEDICAL: BUSINESS OVERVIEW
             10.1.13 CERUS ENDOVASCULAR INC.
                        TABLE 213 CERUS ENDOVASCULAR INC.: BUSINESS OVERVIEW
             10.1.14 ACANDIS GMBH
                        TABLE 214 ACANDIS GMBH: BUSINESS OVERVIEW
                        TABLE 215 ACANDIS GMBH: PRODUCTS OFFERED
             10.1.15 EVASC
                        TABLE 216 EVASC: BUSINESS OVERVIEW
             10.1.16 SENSOME
                        TABLE 217 SENSOME: BUSINESS OVERVIEW
             10.1.17 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.
                        TABLE 218 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.: BUSINESS OVERVIEW
                        FIGURE 36 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD: COMPANY SNAPSHOT (2021)
             10.1.18 IMPERATIVE CARE
                        TABLE 219 IMPERATIVE CARE: BUSINESS OVERVIEW
                        TABLE 220 IMPERATIVE CARE: PRODUCT LAUNCHES AND APPROVALS
             10.1.19 MEDIKIT CO., LTD.
                        TABLE 221 MEDIKIT CO., LTD.: BUSINESS OVERVIEW
             10.1.20 ZYLOX-TONBRIDGE MEDICAL CO., LTD.
                        TABLE 222 ZYLOX-TONBRIDGE MEDICAL CO., LTD.: BUSINESS OVERVIEW
                        FIGURE 37 ZYLOX-TONBRIDGE MEDICAL CO., LTD.: COMPANY SNAPSHOT (2021)
                        TABLE 223 ZYLOX-TONBRIDGE MEDICAL CO., LTD.: PRODUCT LAUNCHES AND APPROVALS
     10.2 OTHER PLAYERS 
             10.2.1 SILK ROAD MEDICAL, INC.
             10.2.2 ARTIO MEDICAL, INC.
             10.2.3 IVASCULAR
             10.2.4 OXFORDENDOVASCULAR
             10.2.5 NEUROVASC TECHNOLOGIES, INC.
 
*Details on Business Overview, Products Offered, Recent Developments, MnM View, Right to win, Strategic choices made, Weaknesses and competitive threats might not be captured in case of unlisted companies.
 
11 APPENDIX (Page No. - 255)
     11.1 DISCUSSION GUIDE 
     11.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 
     11.3 CUSTOMIZATION OPTIONS 
     11.4 RELATED REPORTS 
     11.5 AUTHOR DETAILS 

The objective of the study is analyze the key market dynamics such as drivers, opportunities, challenges, restraints, and key player strategies. To track companies developments such as acquisitions, product launches, expansions, collaborations, agreements and partnerships of the leading players, the competitive landscape of the neurovascular devices market to analyzes market players on various parameters within the broad categories of business and product strategy. Top-down and bottom-up approaches were use to estimate the market size. To estimate the market size of segments and subsegments the market breakdown and data triangulation were used.

The four steps involved in estimating the market size are

Collecting Secondary Data

The secondary research data collection process involves the usage of secondary sources, directories, databases (such as World Health Organization (WHO), World Bank, Organisation for Economic Co-operation and Development (OECD), American Stroke Association (ASA), American Neurological Association (ANS), Society of Therapeutic Neuro Interventions (STNI),  Centers for Disease Control and Prevention (CDC), US Food and Drug Association (FDA) National Institutes of Health (NIH), annual reports, investor presentations, and SEC filings of companies).  Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the market. A database of the key industry leaders was also prepared using secondary research.

Collecting Primary Data

The primary research data was conducted after acquiring knowledge about the market scenario through secondary research. A significant number of primary interviews were conducted with stakeholders from both the demand side (hospitals and surgical centers, ambulatory centers, and research institutes)) and supply-side (such as included various industry experts, such as Directors, Chief X Officers (CXOs), Vice Presidents (VPs) from business development, marketing and product development teams, product manufacturers, wholesalers, channel partners, and distributors) across major countries of North America, Europe, Asia Pacific, the Middle East & Africa, and Latin America.

Approximately 40% of the primary interviews were conducted with stakeholders from the demand side while those from the supply side accounted for the remaining 60%. Primary data for this report was collected through questionnaires, emails, and telephonic interviews.

A breakdown of the primary respondents is provided below:

Breakdown of Primary Participants:

Neurovascular Devices Market Size, and Share

Note 1: *Others include sales managers, marketing managers, and product managers.

Note 2: Tiers are defined based on a company’s total revenue as of 2022: Tier 1=> USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3=< USD 500 million.

To know about the assumptions considered for the study, download the pdf brochure

COMPANY NAME

DESIGNATION

Stryker

General Manager

Medtronic

Senior Product Manager

Johnson & Johnson

Regional Manager

Penumbra, Inc

General Manager of Sales

Market Size Estimation

All major product manufacturers offering various neurovascular devices were identified at the global/regional level. Revenue mapping was done for the major players and was extrapolated to arrive at the global market value of each type of segment. The market value neurovascular devices market was also split into various segments and subsegments at the region and country level based on:

  • Product mapping of various manufacturers for each type of market at the regional and country-level 
  • Relative adoption pattern of each market among key application segments at the regional and/or country-level 
  • Detailed primary research to gather qualitative and quantitative information related to segments and subsegments at the regional and/or country level. 
  • Detailed secondary research to gauge the prevailing market trends at the regional and/or country-level 

Global Market Size: Bottom Up Approach

Neurovascular Devices Market Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Global Market Size: Top Down Approach

Neurovascular Devices Market Size, and Share

Data Triangulation

After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, the data triangulation, and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the Neurovascular devices industry.

Market Definition

Neurovascular devices are used for the minimally invasive treatment of neurological disorders and neurovascular diseases that affect the central nervous system (including brain and spinal cord). These diseases include aneurysms, arteriovenous malformations, intracranial stenosis, atherosclerosis, and Moyamoya disease. Interventional neurology includes angiography, endovascular, and catheter-based techniques, among others.

Key Stakeholders

  • Original Equipment Manufacturers (OEMs)
  • Product Sales And Distribution Companies
  • Healthcare Service Providers (Hospitals And Surgical Centers)
  • Non-Government Organizations
  • Government Regulatory Authorities
  • Ambulatory Care Centers
  • Contract Manufacturers And Third-Party Suppliers
  • Research Laboratories And Academic Institutes
  • Clinical Research Organizations (CROs)
  • Government And Non-Governmental Regulatory Authorities
  • Market Research And Consulting Firms

Report Objectives

  • To provide detailed information about the factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
  • To define, describe, segment, and forecast the neurovascular devices market by disease pathology, end user, and region
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To analyze micro markets with respect to individual growth trends, prospects, and contributions to the overall market
  • To forecast the size of the market in five main regions along with their respective key countries, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
  • To profile key players in the market and comprehensively analyze their core competencies and market shares
  • To track and analyze competitive developments, such as acquisitions; product launches; expansions; collaborations, agreements, & partnerships; and R&D activities of the leading players in the market
  • To benchmark players within the market using the competitive leadership mapping framework, which analyzes market players on various parameters within the broad categories of business and product strategy

Available Customizations

MarketsandMarkets offers the following customizations for this market report:

  • Additional country-level analysis of the Neurovascular devices market
  • Profiling of additional market players (up to 5)

Product Analysis

  • Product matrix, which provides a detailed comparison of the product portfolio of each company in the Neurovascular devices Market
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Request Customization

Instant Answers with GPT - Ask Now!

Ask real questions. Get complete answers !
Report Code
MD 1310
Published ON
May, 2023
REQUEST FREE SAMPLE REPORT
Choose License Type
BUY NOW
Inquire Before Buying
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Neurovascular Devices Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2024 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status Website Feedback